Joint Canada-Israel Health Research Program - Backgrounder
The Joint Canada-Israel Health Research Program is a seven-year, two-phased, CA$35 million partnership between IDRC, the Azrieli Foundation, the Israel Science Foundation, and the Canadian Institutes of Health Research that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine. It is expected to fund more than collaborative projects involving researchers from Canada and Israel, as well as collaborators from low and middle-income countries.
Phase I:
- First call (2015) – Neuroscience
- Second call (2016) – Immunology
- Third call (2017) – Cancer
- Fourth call (2018) – Neurobiology
- Fifth call (2019) – Metabolism
Phase II:
- First call (2022) – Non-communicable chronic diseases and infectious diseases
- Second call (2023) – Communicable diseases
- Date modified: